Excision Medical


Development-stage medical device company focused on catheter-based leaflet modification technology for management of aortic valve stenosis and facilitating redo transcatheter aortic valve replacement (TAVR). Developing steerable catheter systems, a radiofrequency-based excision catheter, and a temporary percutaneous valve to enable targeted leaflet removal prior to valve-in-valve procedures. The leaflet excision system is patent-pending and not FDA approved.

Industries

N/A

Nr. of Employees

small (1-50)

Excision Medical

260 Sierra Drive, STE 120, Exton, PA 19341


Products

Steerable catheter system

Steerable catheter designed to navigate to and position against valve leaflets for targeted leaflet modification during transcatheter procedures.

Radiofrequency excision catheter

Catheter intended to deliver radiofrequency energy to excise failed bioprosthetic valve leaflets as part of leaflet modification.

Temporary percutaneous valve device

Temporary valve intended to provide hemodynamic support during leaflet modification and valve exchange procedures.

Expertise Areas

  • Catheter-based structural heart device development
  • Transcatheter valve-in-valve procedure support
  • Radiofrequency-based tissue excision for cardiovascular use
  • Steerable catheter systems
  • Show More (2)

Key Technologies

  • Radiofrequency tissue excision
  • Steerable catheter mechanics
  • Temporary percutaneous valve devices
  • Catheter-based leaflet removal
  • Show More (1)

News & Updates

Announcement of $2.5M in funding and additions to the scientific advisory board.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.